308 related articles for article (PubMed ID: 37125948)
1. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes Care; 2023 Jun; 46(6):1112-1123. PubMed ID: 37125948
[TBL] [Abstract][Full Text] [Related]
2. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes; 2023 Jun; 72(6):677-689. PubMed ID: 37125945
[TBL] [Abstract][Full Text] [Related]
3. The Potential Causes of Cystic Fibrosis-Related Diabetes.
Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
[TBL] [Abstract][Full Text] [Related]
4. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
Barrio R
Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
[TBL] [Abstract][Full Text] [Related]
5. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
6. Islet-intrinsic effects of CFTR mutation.
Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
[TBL] [Abstract][Full Text] [Related]
7. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
Gaines H; Jones KR; Lim J; Medhi NF; Chen S; Scofield RH
J Diabetes Complications; 2021 Jun; 35(6):107845. PubMed ID: 33558149
[TBL] [Abstract][Full Text] [Related]
8. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
Moheet A; Moran A
J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
[TBL] [Abstract][Full Text] [Related]
9. Advances in cystic fibrosis-related diabetes: Current status and future directions.
Lurquin F; Buysschaert M; Preumont V
Diabetes Metab Syndr; 2023 Nov; 17(11):102899. PubMed ID: 37939435
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study.
Soave D; Miller MR; Keenan K; Li W; Gong J; Ip W; Accurso F; Sun L; Rommens JM; Sontag M; Durie PR; Strug LJ
Diabetes; 2014 Jun; 63(6):2114-9. PubMed ID: 24550193
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment.
Alves C; Della-Manna T; Albuquerque CTM
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):835-843. PubMed ID: 32651985
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
13. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.
Malik SS; Padmanabhan D; Hull-Meichle RL
Front Endocrinol (Lausanne); 2023; 14():1269139. PubMed ID: 38075070
[TBL] [Abstract][Full Text] [Related]
14. Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.
Iafusco F; Maione G; Rosanio FM; Mozzillo E; Franzese A; Tinto N
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33810109
[TBL] [Abstract][Full Text] [Related]
15. The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes.
Hasan S; Khan MS; Lansang MC
J Clin Transl Endocrinol; 2022 Sep; 29():100301. PubMed ID: 35746945
[TBL] [Abstract][Full Text] [Related]
16. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 Is Increased by CFTR Loss of Function, Is Lowered by Insulin, and Increases In Vivo at Onset of CFRD.
Montanini L; Cirillo F; Smerieri A; Pisi G; Giardino I; d'Apolito M; Spaggiari C; Bernasconi S; Amarri S; Street ME
J Clin Endocrinol Metab; 2016 Mar; 101(3):1274-81. PubMed ID: 26760176
[TBL] [Abstract][Full Text] [Related]
18. Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes.
Christian F; Thierman A; Shirley E; Allen K; Cross C; Jones K
J Investig Med High Impact Case Rep; 2019; 7():2324709619842898. PubMed ID: 31010313
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
Hart NJ; Aramandla R; Poffenberger G; Fayolle C; Thames AH; Bautista A; Spigelman AF; Babon JAB; DeNicola ME; Dadi PK; Bush WS; Balamurugan AN; Brissova M; Dai C; Prasad N; Bottino R; Jacobson DA; Drumm ML; Kent SC; MacDonald PE; Powers AC
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669939
[TBL] [Abstract][Full Text] [Related]
20. Glucose intolerance in cystic fibrosis patients.
Lanng S
Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]